High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer

Yihong Wang, Joseph A. Sparano, Susan Fineberg, Lesley Stead, Jaya Sunkara, Susan Band Horwitz, Hayley M. McDaid

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint Dive into the research topics of 'High expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences